New Jersey Gov. Chris Christie held forth at the New Jersey biotechnology association NJ Bio annual meeting last night on a range of topics from Snooki’s tweets about him to the recent return of his chief of staff Richard Bagger to the pharmaceutical industry.Bagger joined Celgene (NYSE:CELG) at the end of January in a newly [...]
[Read more of this report]A drug developer wants to shake up the clinical trial process through crowdsourcing as well as using telemedicine and greater data transparency. It believes implementing these together can cut the cost of doing clinical trials by 50 percent in the next two years.Transparency Life Sciences is a New York-based startup that was founded by CEO [...]
[Read more of this report]Selventa, a biomarker discovery company that enables personalized healthcare through the stratification of patients based on disease-driving mechanisms, recently announced a US patent that relates methods and techniques that facilitate discovery of biomarkers, thus aiding in the development of predictive and prognostic diagnostic tests for therapeutics targeting complex multi-factorial diseases.The Massachusetts-based company uses molecular patient [...]
[Read more of this report]Ossianix, an early stage biopharmaceutical startup that utilizes shark antibodies as a model for drugs to treat central nervous system disorders, has received a strategic investment from Danish pharmaceutical company H Lundbeck.The investment amount was not disclosed, but Dr. Frank Walsh, cofounder and CEO of Ossianix, said it would be enough to fund the company [...]
[Read more of this report]Current medical news from today, including a new report names and highlights nine future biotech clusters, “BSN in 10″ initiative awaits its fate in New York legislature, and what’s ahead for biotech in 2012.
[Read more of this report]Current medical news from today, including where does Florida stand as a biotech cluster?, AVI Biopharma to “refocus” and cut workforce after flu contract failure, and Symmetry Medical purchases J&J subsidiary’s surgical instruments unit.
[Read more of this report]Temple University’s Moulder Center for Drug Discovery Research in Philadelphia, Pennsylvania has formed a collaboration with India-based GVK Biosciences to identify biomarkers.GVK Bio will be responsible for the target validation, lead identification and lead optimization of small molecules in selected therapeutic areas, including cardiovascular, metabolic and central nervous system disorders.The Moulder Center, opened in 2009, [...]
[Read more of this report]New Jersey has allocated $60 million to 75 emerging biotechnology and technology companies through a tax credit program, according to a statement from the state’s Economic Development Authority.It is a $30 million increase over the previous fiscal year.The funds are made available through the state’s Technology Business Tax Certificate Transfer Program. Gov. Chris Christie’s fiscal [...]
[Read more of this report]BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, has appointed Sam Katz, one of its co-founders and aninvestor in the region, as board chairman and named two new directors to its board.Katz takes over from Philip Gerbino,president of the University of the Sciences, who will continue to serve on the board.Katz is a partner and CEO [...]
[Read more of this report]The Innovation Forum at the Biotech 2011 conference in Philadelphia this week sought to put scientists and early stage startups from universities and incubators in the region in front of investors and alongside other, more mature startups to provide opportunities for investment and partnerships.Judith Sheft, associate vice president for technology and development at the New [...]
[Read more of this report]